Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2024 / Mar / Resistance is Futile
Microbiology & Immunology Microbiology and Immunology Screening and monitoring Bioinformatics Research and Innovations

Resistance is Futile

The role of microbiology diagnostics data in antimicrobial resistance surveillance and monitoring

By Ana Ortiz, Ignasi Baliarda, Helen Bristow 03/22/2024 Technology 3 min read

Share

As antimicrobial resistance becomes increasingly common, a precise microbiological diagnosis – along with the determination of antimicrobial susceptibility and the minimum inhibitory concentration (MIC) for antibiotics – is fundamental to its combat.

Here we examine some of the ways in which microbiology diagnostics contribute to the timely detection and surveillance of drug-resistant pathogens, and the technology and initiatives that help us achieve that.

Microbiology diagnostics
 

The microbiological diagnosis, through the determination of the MIC, provides information on the susceptibility of pathogens to various antimicrobials. Likewise, the microbiological diagnosis can allow the detection of the main multi-resistant microorganisms that can be the cause of therapeutic failures and even patient’s death. This can then activate alerts for the control and exhaustive surveillance of multi-resistance strains to mitigate their spread.

Microbiology laboratories monitor the trend and evolution not only of resistance itself but also of the year-on-year increases in MIC50 and MIC90 for some antimicrobials of special interest. Without a doubt, a correct microbiological diagnosis is the starting point to establish truly effective surveillance.

Ana Ortiz

Patient data analysis tools
 

Correct interpretation of pathogen identification or an antimicrobial sensitivity test requires basic patient data such as: where the sample was collected, previous positive samples, and more. But the data need to be selected judiciously – too much information could hinder a clinical decision.

Integrative middleware tools, such as HighFlexX, are available to enhance the microbiological diagnostic process. They can merge a wide range of data, such as patient demographic data, sample data from the laboratory information system historical archives, and ongoing samples from different diagnostic systems. The implementation of such tools can lead to improved productivity, efficient workflows, standardized processes, and a reduction in human errors.

Importantly, this connected environment enables the knowledge gained from microbial analyses to contribute seamlessly to the broader healthcare narrative. With a simple “click,” staff can obtain a visually integrated dashboard by searching for a patient name, sample number, or culture, which optimizes customer loyalty to the system.

Interconnected systems facilitate an efficient workflow in the microbiology laboratory. For example, the MicroScan products, to determine the susceptibility of antimicrobials, and mass spectrometry for bacterial identification can be integrated via HighFlexX middleware. Laboratories using this solution have reported satisfaction with its ease of use, robustness, and versatility.

Ignasi Baliarda

Antimicrobial stewardship
 

Clinicians can establish effective isolation measures, and provide appropriate treatment to reduce antibiotic pressure and treat the infection. But how can society in general help with the resistance battle?

International organizations are already raising awareness about a “One Health Response” to address the issue of antimicrobial resistance. This multidisciplinary approach includes medical, veterinary, agricultural, environmental, and other relevant fields. Since the use and abuse of antimicrobials is widespread in various areas, measures need to be taken in all of them to tackle the issue of antimicrobial resistance.

To this end, it should be noted that more and more centers have established antimicrobial stewardship committees that are directly involved in projects such as “Sepsis code”, “Zero resistance”, or “PROA project”. All of them aim to achieve responsible use of antimicrobials to reduce the number of infections due to multidrug-resistant microorganisms.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Ana Ortiz

Sales representative for MicroScan products for Beckman Coulter in Spain

More Articles by Ana Ortiz

Ignasi Baliarda

Manager of Application Microbiology Support for Beckman Coulter in Spain

More Articles by Ignasi Baliarda

Helen Bristow

Combining my dual backgrounds in science and communications to bring you compelling content in your speciality.

More Articles by Helen Bristow

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Context Matters in Cancer Biology
Microbiology and Immunology
Context Matters in Cancer Biology

December 27, 2021

1 min read

Akoya is leading the way with spatial phenotypic signatures – a novel class of biomarkers for predicting response to immunotherapy

What’s New in Infectious Disease? (December 2021)
Microbiology and Immunology
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Immunology Insights
Microbiology and Immunology
Immunology Insights

January 13, 2022

1 min read

The latest research in pathology and laboratory medicine

2021: A Laboratory Medicine Roundup
Microbiology and Immunology
2021: A Laboratory Medicine Roundup

January 18, 2022

3 min read

From transgender health care to the power of pathology podcasts, we take a look at our most popular articles of the last year

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.